Cross, H. A.
6026  Ergebnisse:
Personensuche X
?
1

Effects of ganaxolone on non-seizure outcomes in CDKL5 Defi..:

Downs, J. ; Jacoby, P. ; Specchio, N....
European Journal of Paediatric Neurology.  51 (2024)  - p. 140-146 , 2024
 
?
2

P.014 Intravenous immunoglobulin use for central nervous sy..:

Beadon, K ; Uy, C ; Cross, H...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S18-S18 , 2024
 
?
 
?
5

69 Continuous and Regular Live Feedback is Required to Main..:

Cross, H ; Evans, J ; Pederson, A...
Age and Ageing.  50 (2021)  Supplement_1 - p. i12-i42 , 2021
 
?
6

The impact of COVID-19 on epilepsy care: Perspectives from ..:

Thorpe, J. ; Ashby, S. ; Cross, J.H....
Epilepsy & Behavior Reports.  16 (2021)  - p. 100487 , 2021
 
?
8

New ways forward in childhood epilepsy – Fact or hype:

Cross, H.
Journal of the Neurological Sciences.  405 (2019)  - p. 57-58 , 2019
 
?
9

The VCCC Research & Education Lead Program: Collective Lead..:

Layton, M. ; Johnson, E. ; Hall, S....
Journal of Global Oncology.  4 (2018)  Supplement 2 - p. 156s-156s , 2018
 
?
10

Eslicarbazepine acetate as add-on therapy for focal seizure..:

Chiron, C. ; Cross, J.H. ; Feucht, M....
European Journal of Paediatric Neurology.  21 (2017)  - p. e38 , 2017
 
?
12

Efficacy and safety of cannabidiol as add-on therapy in dru..:

Vezyroglou, K. ; Eltze, C. ; Varadkar, S....
European Journal of Paediatric Neurology.  21 (2017)  - p. e87 , 2017
 
?
 
?
15

Established and novel disease‐modifying treatments in multi..:

Cross, A. H. ; Naismith, R. T.
Journal of Internal Medicine.  275 (2014)  4 - p. 350-363 , 2014
 
1-15